Carboplatin and cisplatin are 2 of 15 cancer drugs on the FDA’s drug shortage list. According to manufacturers, this shortage is largely due to manufacturing and supply chain issues. Many mesothelioma patients have chemo treatment plans that include these 2 drugs.
The shortage of these drugs may affect mesothelioma patients undergoing treatment. For instance, the shortage may have led to appointment rescheduling for some patients. It may also cause worry for patients about their prognosis and treatment.
But luckily, mesothelioma doctors are dedicated to finding solutions for their patients. These solutions may include choosing other treatments and drugs. Some doctors may also ration their supplies of these chemo drugs. This helps patients to continue receiving some of their planned doses.
Mesothelioma patients may wonder what to expect for themselves. Each case will be different, depending on various individual factors. But in general, some treatment plan adjustments are more common than others.
Source link
#U.S #Drug #Shortage #Update #Impact #Mesothelioma
